The Humanity Project
Disclaimer: I run Edison Scientific, a company building an AI Scientist to automate scientific research and development. Our AI Scientist supports partners in biotech and pharma across the entire pipeline of drug development, including hypothesis generation, target identification, and target validation as discussed here, among other things.GLP-1 agonists are revolutionizing humanity’s approach to weight loss. The odds are that there are very many other GLP-1-like treatments -- extremely effectiv
Disclaimer: I run Edison Scientific, a company building an AI Scientist to automate scientific research and development. Our AI Scientist supports partners in biotech and pharma across the entire pipeline of drug development, including hypothesis generation, target identification, and target validation as discussed here, among other things. GLP-1 agonists are revolutionizing humanity’s approach to weight loss. The odds are that there are very many other GLP-1-like treatments -- extremely effective, with minimal side-effects -- waiting to be found for other major diseases, from cancer to aging.
Explore this link on the map →related reading
- Dario Amodei — Machines of Loving Gracedarioamodei.com
- Dario Amodei — Machines of Loving Gracedarioamodei.com
- What will it take for AI to change drug discovery?writingruxandrabio.com
- Gap Mapgap-map.org
- Nature's drug database - The Works in Progress Newsletterworksinprogress.news
- Dario Amodei — Machines of Loving Gracedarioamodei.com
- Where are all the trillion dollar biotechs?ladanuzhna.xyz
- Nature’s laboratory - Works in Progress Magazineworksinprogress.co
- Rebuild Biotech for the AI Era | Benchlingbenchling.com
- Why is progress in biology so slow?sam-rodriques.com
- The pharma industry from Paul Janssen to today: why drugs got harder to develop and what we can do about it | Alex’s blogatelfo.github.io
- AI for Alzheimer’sopenaifoundation.org